A.I. VALI Inc.

A.I. VALI delivers AIDREA, an agnostic AI platform for real-time medical image analysis, improving diagnosis, workflow, and reporting, with 20x ROI—transforming care in clinics and clinical trials.

Started commercialization in Canada and secured multiple hospitals and private clinics during the past 6 months.

Manual interpretation of medical images causes diagnostic errors, leading to more than 800K deaths and disabilities every year. The cost of mitigating these challenges is huge for healthcare systems, insurance, and payers. Errors and delays also impact the quality of life for patients.

AIDREA is an agnostic AI platform, provides real-time image analysis, captures all the information during procedures such as endoscopy, and generates standardized patient and billing/reimbursement reports. It is approved as Class I by Health Canada and the FDA. Based on 2 clinical trials, AIDREA increases the accuracy of diagnosis, reduces cost/patient, improves the profitability of the clinic, and generates evidence-based documents for insurance and payers. The estimated ROI is 20X.

Our business model is B2B, direct sales to hospitals, private clinics, and insurance/payers. Other clients are the pharma/biotech industries and Contract Research Organizations.

Creative Destruction Labs, MaRS , Innovation Factory, Next AI